Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 21247551.
- Also identified by DOI 10.1016/j.ajog.2010.10.897 and PMC identifier 4598044.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to determine the usefulness of a simple screening tool for bleeding disorders in a multisite population of women with menorrhagia. Women with menorrhagia between the ages of 18 and 50 years from 6 geographically diverse US centers underwent hemostatic testing for bleeding disorders, complete blood cell count, and ferritin. A questionnaire that contained all elements of the 8-question screening tool was administered. Sensitivity of the screening tool, a screening tool with a pictorial blood assessment chart (PBAC) score of >185, and a screening tool with serum ferritin were calculated for hemostatic disorders. Two hundred and seventeen women who were identified with a PBAC score of ≥100 participated in the study. The sensitivity of the screening tool was 89% for hemostatic defects, and sensitivity increased to 93% and 95% with a serum ferritin level of ≤20 ng/mL and a PBAC score of >185, respectively. This study confirms the usefulness of a short screening tool for the stratification of women with menorrhagia for hemostatic evaluation.
Medical subject headings
- Hemorrhagic Disorders
- Mass Screening
- Menorrhagia